1. Kurlan R, Rothfield KP, Woodward WR, et al. Erratic gastric emptying of levodopa may cause “random” fluctuations of parkinsonian mobility. Neurology. 1988; 38:419–421.
Article
2. Nyholm D, Nilsson Remahl AI, Dizdar N, et al. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Neurology. 2005; 64:216–223.
Article
3. Cheron J, Deviere J, Supiot F, et al. The use of enteral access for continuous delivery of levodopa-carbidopa in patients with advanced Parkinson’s disease. United European Gastroenterol J. 2017; 5:60–68.
Article
4. Epstein M, Johnson DA, Hawes R, et al. Long-term PEG-J tube safety in patients with advanced Parkinson’s disease. Clin Transl Gastroenterol. 2016; 7:e159.
Article
5. Klostermann F, Jugel C, Bömelburg M, Marzinzik F, Ebersbach G, Müller T. Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion. Mov Disord. 2012; 27:1704–1705.
Article
6. Schrader C, Böselt S, Wedemeyer J, Dressler D, Weismüller TJ. Asparagus and jejunal-through-PEG: an unhappy encounter in intrajejunal levodopa infusion therapy. Parkinsonism Relat Disord. 2011; 17:67–69.
Article
7. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology. 2001; 57:456–462.
Article
8. Marano M, Pizzicannella M, di Biase L, et al. Jejunal pulling syndrome: a peculiar LCIG complication. Parkinsonism Relat Disord. 2018; 52:113–114.
Article